| ACT | Adoptive cell-based therapy |
| ADCC | Antibody-dependent cellular cytotoxicity |
| BiTEs | Bispecific T-cell engagers |
| CAR | Chimeric antigen receptor |
| CBL-B | Casitas B-lineage lymphoma proto-oncogene-B |
| CISH | Cytokine inducible SH2 containing protein |
| COVERT | Cytoplasmic oncoprotein verifier and response trigger |
| CRS | Cytokine release syndrome |
| CTLA-4 | Cytotoxic T-lymphocyte antigen 4 |
| dCas9 | Dead CRISPR associated protein 9 |
| DGK | Diacylglycerol kinase |
| EGFR | Epidermal growth factor receptor |
| EpoR | Erythropoietin receptor |
| GEARs | Generalized engineered activation regulators |
| GEMS | Generalized extracellular molecules sensors |
| GM-CSF | Granulocyte-macrophage colony stimulating factor |
| GPCRs | G protein-coupled receptors |
| GrzB | Granzime B |
| HIF-1α | Hypoxia-inducible factor-1α |
| iCAR | Inactivating CAR |
| ICOS | Inducible T cell co-stimulator |
| IDO-1 | Indoleamine 2,3-dioxygenase 1 |
| IFN | Interferon |
| irAEs | Immune-related adverse events |
| ITAM | Immunoreceptor tyrosine-based activation motif |
| ITIM | Immunoreceptor tyrosine-based inhibitory motif |
| JAK/STAT | Janus kinase/signal transducer and activator of transcription |
| LAG-3 | Lymphocyte-activation gene-3 |
| LOH | Loss of heterozygosity |
| MAPK | Mitogen-activated protein kinase |
| MCP | MS2 bacteriophage coat protein |
| MDSC | Myeloid-derived suppressor cells |
| MHC | Major histocompatibility complex |
| MRSA | Methicillin resistant Staphylococcus aureus |
| NR4A | Nuclear receptor 4 A |
| PD-1/PD-L1 | Programmed cell death protein-1/Programmed cell death protein-ligand 1 |
| PI3K/Akt | Phosphatidylinositol 3-kinase/Protein kinase B |
| PLC-γ | Phospholipase C gamma |
| PSMA | Prostate-specific membrane antigen |
| PTPN22 | Protein tyrosine phosphatase, non-receptor type 22 |
| RASAL1 | RAS protein activator like 1 |
| sCARs | Switchable CAR-T-cells |
| scFv | Single chain variable fragment of an antibody |
| SENP1 | Sentrin-specific protease 1 |
| sgRNA | Synthetic guide RNA |
| SHP1 | Src homology 2 domain-containing protein tyrosine phosphatase 1 |
| SOCS1 | Suppressor of cytokine signaling 1 |
| SUMO | Small ubiquitin-like modifier |
| SUPRA CAR | Split universal programmable CAR |
| SynNotch | Synthetic Notch |
| TAAs | Tumor-associated antigens |
| TCE | T cell exhaustion |
| TCM | T central memory |
| TCR | T cell receptor |
| TEV | Tobacco etch virus |
| TGFβ | Transforming growth factor beta |
| TGFβRII | Transforming growth factor beta receptor 2 |
| TIGIT | T cell immunoreceptor with Ig and ITIM domains |
| TILs | Tumor infiltrating lymphocytes |
| TIM-3 | T-cell immunoglobulin and mucin domain-3 |
| TLRs | Toll-like receptors |
| TME | Tumor microenvironment |
| TNFR | Tumor necrosis factor receptor |
| TOX | Thymocyte selection-associated high mobility group box protein |
| TRUCKs | T cells redirected for universal cytokine-mediated killing |
| VEGF | Vascular endothelial growth factor |